89 related articles for article (PubMed ID: 8531711)
1. Biochemical analysis of SH2 domain-mediated protein interactions.
Gish G; Larose L; Shen R; Pawson T
Methods Enzymol; 1995; 254():503-23. PubMed ID: 8531711
[No Abstract] [Full Text] [Related]
2. Determinants of DNA-binding specificity of ETS-domain transcription factors.
Shore P; Whitmarsh AJ; Bhaskaran R; Davis RJ; Waltho JP; Sharrocks AD
Mol Cell Biol; 1996 Jul; 16(7):3338-49. PubMed ID: 8668149
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Elk-1 ETS DNA-binding domain.
Shore P; Bisset L; Lakey J; Waltho JP; Virden R; Sharrocks AD
J Biol Chem; 1995 Mar; 270(11):5805-11. PubMed ID: 7890710
[TBL] [Abstract][Full Text] [Related]
4. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
5. SH2 domain proteins as high-affinity receptor tyrosine kinase substrates.
Sierke SL; Koland JG
Biochemistry; 1993 Sep; 32(38):10102-8. PubMed ID: 7691170
[TBL] [Abstract][Full Text] [Related]
6. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
[TBL] [Abstract][Full Text] [Related]
7. SH2 domain specificity determination using oriented phosphopeptide library.
Songyang Z; Cantley LC
Methods Enzymol; 1995; 254():523-35. PubMed ID: 8531712
[No Abstract] [Full Text] [Related]
8. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
10. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.
Cunningham SA; Arrate MP; Brock TA; Waxham MN
Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells.
Aoki Y; Isselbacher KJ; Cherayil BJ; Pillai S
Proc Natl Acad Sci U S A; 1994 May; 91(10):4204-8. PubMed ID: 7514299
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.
Landgren E; Klint P; Yokote K; Claesson-Welsh L
Oncogene; 1998 Jul; 17(3):283-91. PubMed ID: 9690510
[TBL] [Abstract][Full Text] [Related]
13. Formation of signal transfer complexes between stem cell and platelet-derived growth factor receptors and SH2 domain proteins in vitro.
Herbst R; Shearman MS; Jallal B; Schlessinger J; Ullrich A
Biochemistry; 1995 May; 34(17):5971-9. PubMed ID: 7537096
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
15. Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl.
Grossmann AH; Kolibaba KS; Willis SG; Corbin AS; Langdon WS; Deininger MW; Druker BJ
FEBS Lett; 2004 Nov; 577(3):555-62. PubMed ID: 15556646
[TBL] [Abstract][Full Text] [Related]
16. Grb2 binding to the different isoforms of Ret tyrosine kinase.
Alberti L; Borrello MG; Ghizzoni S; Torriti F; Rizzetti MG; Pierotti MA
Oncogene; 1998 Sep; 17(9):1079-87. PubMed ID: 9764818
[TBL] [Abstract][Full Text] [Related]
17. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
18. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
[TBL] [Abstract][Full Text] [Related]
19. The ETS-domain transcription factors Elk-1 and SAP-1 exhibit differential DNA binding specificities.
Shore P; Sharrocks AD
Nucleic Acids Res; 1995 Nov; 23(22):4698-706. PubMed ID: 8524663
[TBL] [Abstract][Full Text] [Related]
20. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
